Observational Recruiting
NCT07777744 on ClinicalTrials.gov
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
Official title: Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation - an International Multicenter Collaborative Study Group
- Sponsor: University Hospital of Basel
- Enrollment: 15000 (Estimated)
- Study start: 2024-07-01 (Actual)
- Primary completion: 2028-12-31 (Estimated)
- Study completion: 2028-12-31 (Estimated)
- Allocation: N/a
- InterventionModel: N/a
- Masking: None
- PrimaryPurpose: Other
Brief Summary
The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.
Conditions
- Ventricular Tachycardia (VT)
- Premature Ventricular Complexes
Primary Outcome Measures
-
Descriptive characterization of patients
(up to 30 days)
characterizing features: * hemodynamic instability requiring mechanical intensive-care management * tamponade * stroke * cardiac arrest * myocardial infarction * coronary artery dissection * phrenic nerve palsy * major bleeding as per the International Society on Thrombosis and Haemostasis (ISTH) * vascular or cardiac complication requiring surgery or interventional management (interventional radiology, angiology) * iatrogenic atrio-ventricular block requiring device implantation or upgrade. * procedure-related death
Countries
Austria, Canada, China, Croatia, France, Germany, Greece, Israel, Italy, Singapore, Slovenia, Spain, Switzerland, Turkey (Türkiye), United Kingdom, United States
Locations and Investigators
-
Rush University Medical Center, Chicago, United States (Recruiting)
- Henry Huang
-
University of Michigan, Michigan Center, United States (Recruiting)
- Jackson Liang
-
Medical University of Graz, Graz, Austria (Recruiting)
- Daniel Scherr
-
Université Laval, Québec, Canada (Recruiting)
- Jean-Francois Sarrazin
-
The First Affiliated Hospital of Nanjing Medical University, Nanjing, China (Recruiting)
- Fengxiang Zhang
-
University Hospital Center Sestre milosrdnice, Zagreb, Croatia (Recruiting)
- Nikola Pavlovic
-
CHU Bordeaux, Bordeaux, France (Recruiting)
- Frederic Sacher
-
Centre Hospitalier Universitaire Trousseau, Chambray-lès-Tours, France (Recruiting)
- Alexandre Bodin
-
University Hospital Poitier, Poitiers, France (Recruiting)
- Rodrigue Garcia
-
Clinique Pasteur Toulouse, Toulouse, France (Recruiting)
- Serge Boveda
-
Zentralklinik Bad Bercka, Bad Berka, Germany (Recruiting)
- Ahmad Kelani
-
Uniklinik Freiburg, Bad Krozingen, Germany (Recruiting)
- Heiko Lehrmann
-
Carl-Thiem-Klinikum, Cottbus, Germany (Recruiting)
- Dirk Grosse Meininghaus
-
Universitätsklinikum Münster, Münster, Germany (Recruiting)
- Lars Eckardt
-
University of Patras, Pátrai, Greece (Recruiting)
- Georgios Leventopoulos
-
Sheba Medical Center, Ramat Gan, Israel (Recruiting)
- Eyal Nof
-
Citta della Salute e della Scienza di Torino, Torino, Italy (Recruiting)
- Matteo Anselmino
-
Mount Elisabeth Medical Centre, Singapore, Singapore (Recruiting)
- Pipin Kojodjojo
-
University Medical Center Ljubljana, Ljubljana, Slovenia (Recruiting)
- Andrej Pernat
-
Hospital Universitario Ramón y Cajal, Madrid, Spain (Recruiting)
- Javier Moreno
-
University Hospital Basel, Basel, Switzerland (Recruiting)
- Michael Kühne, Prof. Dr. med.
- Patrick Badertscher, PD Dr. med.
- Michael Kühne, Prof. Dr. med. (Principal Investigator)
-
Inselspital Bern, Bern, Switzerland (Recruiting)
- Tobias Reichlin
-
Ankara City Hospital, Ankara, Turkey (Türkiye) (Recruiting)
- Serkan Cay
-
Hacettepe University, Ankara, Turkey (Türkiye) (Recruiting)
- Hikmet Yorgun
-
Royal Papworth Hospital, Cambridge, United Kingdom (Recruiting)
- Claire Martin
Study Officials
- Michael Kühne, Prof. Dr. med. (Principal Investigator) — University Hospital, Basel, Switzerland